Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer
NCT01751529
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
PROCEDURE:
Contrast-enhanced Ultrasound
DRUG:
Perflutren lipid
Sponsor
UNC Lineberger Comprehensive Cancer Center